RaySearch Collaborates with GE Healthcare to Improve Radiation Oncology Treatment Planning


STOCKHOLM, May 9, 2022 /PRNewswire/ — RaySearch Laboratories AB (publ) is proud to announce a collaboration agreement with GE Healthcare, one of the world’s leading medical technology, diagnostics and digital solutions companies, to develop a novel radiation therapy simulation and treatment planning solution, designed to take advantage of the latest advances in treatment planning technology.

The companies aim to combine RaySearch’s advanced RayStation®* treatment planning system with GE Healthcareleading multi-modality simulation systems (CT/MRI/molecular imaging) to make cancer treatment faster and more accurate.

More than 60% of cancer patients undergo radiation therapy according to the US National Institutes of Health1, which requires high-quality imaging to precisely target tumors while sparing healthy tissue. Precision imaging is fundamental to determining the size, shape and characteristics of tumors and differentiating healthy tissue. A key issue for oncologists can be the cumbersome simulation process and the need to manually navigate multiple systems and workflows. The goal of the collaboration is to simplify this process by enabling point-of-care decision making in the simulation room.

GE Healthcare and RaySearch aim to enable hospitals and cancer treatment centers to implement an interoperable and integrated workflow that will optimize their clinical planning and operational outcomes. As vendors seek to automate radiation oncology processes in the face of increasing patient numbers and advances in radiation therapy treatment delivery procedures, GE and RaySearch are working to bring together complementary technologies and solutions to advance innovation and help the radiation oncology community.
Jan Makela, President and CEO, Imaging, GE Healthcare, said, “GE Healthcare is delighted to partner with RaySearch as we seek to improve precision guidance when planning and treating radiation therapy. Cancer care can only be improved if the people involved work together. and it is one of the many partnerships we pursue for the benefit of caregivers and patients. Clinicians tell us that navigating through multiple systems to get a clear picture of where cancer cells are is one of their biggest problems. We strive to bring complementary solutions and technologies together throughout the radiation therapy treatment journey to help achieve this.”

Johan Löf, Founder and CEO of RaySearch Laboratories, says, “Software has enormous potential, and is now driving innovation in oncology. We are very pleased to work with a partner of the caliber of GE Healthcare, one of the largest providers of precision healthcare, to bring scientific advancements to the clinical world. Our solutions already support thousands of clinics worldwide in the fight against cancer.

About GE Healthcare
GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE). As a global leader in medical technology, pharmaceutical diagnostics and digital solutions innovation, GE Healthcare empowers clinicians to make faster, more informed decisions through smart devices, data analytics, apps and services, supported by its Edison intelligence platform. With more than 100 years of experience in the healthcare industry and approximately 48,000 employees worldwide, the company operates at the center of an ecosystem driving precision health, digitizing healthcare, helping to drive the productivity and improve outcomes for patients, providers, health systems and researchers around the world.

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions to improve cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the RayCare®* oncology information system (OIS). The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®. RayIntelligence is an oncology analytics system (OAS) that enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.

RaySearch software is used by over 800 clinics in over 40 countries. The company was founded in 2000 as a spin-off from Stockholm’s Karolinska Institutet and the stock has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.

About RayStation
RayStation®* is a flexible and innovative treatment planning system chosen by many leading cancer centers around the world. It combines unique features such as unrivaled adaptive therapy capabilities, multi-criteria optimization, market leading algorithms for optimizing treatment plans for HDR brachytherapy and external beam therapy with photons, electrons and protons , as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing a control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also integrates seamlessly with RayCare®*. By harmonizing treatment planning, the care of cancer patients worldwide is improved.

1. NIH National Cancer Institute, Radiation Therapy and You: Support for People with Cancer, NIH Publication No. 17-7157, October 2016.

* Subject to regulatory approval in certain markets.


Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Phone: +46 (0)8 510 530 00, [email protected]earchlabs.com

Björn Hårdemark, Acting Chief Financial Officer, RaySearch Laboratories AB (publ)
Phone: +46 (0)709 564 217, [email protected]

This information was brought to you by Cision http://news.cision.com


The following files are available for download:

View original content: https://www.prnewswire.com/news-releases/raysearch-collaborates-with-ge-healthcare-to-improve-radiation-oncology-treatment-planning-301542388.html

SOURCE RaySearch Laboratories

Company Codes: Bloomberg: [email protected], ISIN: SE0000135485, RICS: RAYB.ST, Stockholm: RAY-B


Comments are closed.